Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00950664Phase 4Completed
Phase 4, randomised, double-blind trial of botulinum toxin type A in cervical dystonia (CD), sponsored by Seoul National University Hospital. Primary endpoint: Tsui Score at 4 weeks. Started Aug 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00950664.